Biocon gets Health Canada nod for micafungin injection, which is indicated for use in adults and children four months and older for treatment of patients with Candidemia. The market size of the said injection has not been disclosed.
Biocon gets Health Canada nod for micafungin injection, which is indicated for use in adults and children four months and older for treatment of patients with Candidemia. The market size of the said injection has not been disclosed.